From dopamine to salience to psychosis—linking biology, pharmacology and phenomenology of psychosis
Top Cited Papers
- 1 November 2005
- journal article
- review article
- Published by Elsevier in Schizophrenia Research
- Vol. 79 (1), 59-68
- https://doi.org/10.1016/j.schres.2005.01.003
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- The search for novel antipsychotics: pharmacological and molecular targetsEmerging Therapeutic Targets, 2004
- Dopamine, learning and motivationNature Reviews Neuroscience, 2004
- Quetiapine in schizophrenia: onset of action within the first week of treatmentCurrent Medical Research and Opinion, 2004
- Cognitive–behavioural therapy in first-episode and early schizophreniaThe British Journal of Psychiatry, 2004
- A Psychiatric Dialogue on the Mind-Body ProblemAmerican Journal of Psychiatry, 2001
- A Rating Scale for Psychotic Symptoms (RSPS): Part I: theoretical principles and subscale 1: perception symptoms (illusions and hallucinations)Schizophrenia Research, 1999
- The Prodromal Phase of First-episode Psychosis: Past and Current ConceptualizationsSchizophrenia Bulletin, 1996
- The involvement of nucleus accumbens dopamine in appetitive and aversive motivationBehavioural Brain Research, 1994
- The Origins of DelusionThe British Journal of Psychiatry, 1992
- Effects of dopamine receptor blockade on avoidance performance: assessment of effects on cue—shock and response—outcome associationsBehavioral and Neural Biology, 1982